Andrea Apolo, M.D.(@apolo_andrea) 's Twitter Profile Photo

BONSAI study tested 1L in 23 patients with metastatic kidney reported an ORR 35%. We have a Collecting Duct Cohort in the Alliance for Clinical Trials in Oncology ICONIC study for of combination cabozantinib/nivolumab/ipilimumab OncoAlert

BONSAI study tested 1L #cabozantinib in 23 patients with metastatic kidney #CollectingDuctCarcinoma reported an ORR 35%. We have a Collecting Duct Cohort in the @ALLIANCE_org ICONIC study for #rareGUtumors of combination cabozantinib/nivolumab/ipilimumab #ESMO21 @OncoAlert
account_circle
Tian Zhang, MD, MHS(@TiansterZhang) 's Twitter Profile Photo

Wonderful news, Andrea Apolo, M.D. and Alliance for Clinical Trials in Oncology! The ICONIC trial will help us learn so much about treating rare GU tumors. Thank you for leading the way forward to improve treatments for these rare but important patients!

account_circle